StockClub
SLXNWSilexion Therapeutics Ltd.$ --
Silexion Therapeutics Ltd.

Silexion Therapeutics Ltd.

SLXNW

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2025/12 Filed: 2026-03-17

Total Assets

account_balance
7.2M USD
No comparison

Shareholders' Equity

savings
2.6M USD
No comparison

Equity Ratio

pie_chart
36.1%
No comparison

Book Value Per Share

paid
4.64USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
403020100
2021
2022
2023
2024
2025

Balance Sheet Details

Item
2020
2021
2022
2023
2024
2025
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
5.99M
5.99M
0
0
0
646,000
6.64M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
0
437,000
437,000
57,000
0
84,000
7.21M
578,000
7.21M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
787,000
182,000
182,000
0
1.74M
2.76M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
286,000
468,000
0
1.57M
-5.52M
1.85M
4.61M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
42,000
1.33M
57.73M
-55.17M
0
0
0
2.60M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.